Clearside Biomedical's Xipere (triamcinolone acetonide injectable suspension) approved by Health Canada, among other company news

Published on August 1, 2025
Additionally, the company is exploring different strategic alternative to advance its suprachoroidal space (SCS) platform and drug development pipeline.
Continue reading on website
Other news

Alcon commercially launches Tryptyr (acoltremon ophthalmic solution) 0.003% for signs and symptoms of DED in the US

August 1, 2025
The solution was approved by the US Food and Drug Administration in late May 2025.

Monthly pipeline update: A July news roundup

August 1, 2025
The latest in drug and technology developments and updates from July 2025.